The current issue of Cardio News, the official publication of the German Society of Cardiology (DGK), focuses on Cardio Explorer®. The AI-supported medical device software offers a pioneering method for the precise determination of the pre-test probability for coronary heart disease (CHD), a decisive step towards efficient and targeted CHD diagnostics. The authors Dr. Thomas M. Helms, Prof. Christian A. Perings and Prof. B. Andrew Remppis present the promising possibilities of this modern approach.
The precise diagnosis of heart disease is crucial in order to initiate appropriate treatment measures in good time and improve patients' quality of life. The current issue of Cardio News, the renowned journal of the German Society of Cardiology (DGK), presents Cardio Explorer®, an AI-based software tool that revolutionizes the determination of the pre-test probability for coronary heart disease (CHD).
A precise pre-test probability is a decisive factor for targeted and efficient CHD diagnostics. It enables treating physicians to take the right diagnostic measures to detect the disease at an early stage and create customized treatment plans. Cardio Explorer® uses advanced artificial intelligence to calculate the clinical probability of CHD in a highly accurate way, based on the patient's individual health data and risk factors.
In their article, the authors Dr. Thomas M. Helms, Prof. Christian A. Perings and Prof. B. Andrew Remppis explain the advantages of this innovative approach. They emphasize how Cardio Explorer® helps to optimize diagnostic processes and take patient care to a new level. This groundbreaking technology promises to protect patients' heart health and improve the way healthcare professionals work in the field of CHD diagnostics. The Cardio Explorer® is an impressive example of how the integration of AI into medicine is paving the way for more precise and personalized healthcare solutions.
Link to the article in Cardio News: "The right diagnostics at the right time"
About the authors:
Dr. Thomas M. Helms is a board member of the German Foundation for the Chronically Ill, a renowned specialist in internal medicine and cardiology with many years of clinical experience. Since 1998, he has headed the Peri Cor Cardiology Working Group, which focuses on clinical electrophysiology and invasive cardiology, clinical and experimental research, education, training and consulting in the healthcare sector. He is a member of the European Society of Cardiology (ESC), the International Medical Science Academy (IMSA) and the German Society of Cardiology and Cardiovascular Research (DGK), where he is the spokesperson for the eCardiology "Society and Politics" committee and a member of the Telemonitoring working group (AG 33). He is also a member of the Digital Medicine Commission and a member of the m-Health Task Force of the German Society of Internal Medicine (DGIM).
Prof. Dr. med. Christian Perings is Chief Physician at the Clinic for Cardiology, Electrophysiology, Pneumology & Intensive Care Medicine at the Catholic Hospital Lünen. He is a specialist in internal medicine, cardiology, pneumology and intensive care medicine and is also a recognized European Cardiologist with additional qualifications in special rhythmology, interventional cardiology and heart failure. As a member and spokesperson for the DGK working group on telemonitoring, he develops medical, technological, logistical, data security and legal regulations for telemedicine. Since March 2020, he has been an appointed member of the GBA Expert Pool and an appointed member of the DGK's e-Cardiology Commission with responsibility for transsectoral strategies. He is also co-editor of the journal Aktuelle Kardiologie.
Prof. Dr. med. Bjoern Andrew Remppis is Director of the Clinic for Cardiology at the Heart and Vascular Center (HGZ) Bad Bevensen. His pioneering contributions to serological infarct diagnostics, in particular the development of the troponin T test as the new gold standard in infarct diagnostics, have had a lasting impact on the field of cardiology. In molecular heart failure research, he played a key role in the identification of the Ca-binding protein S100A1 as a central regulator of myocardial contractility and in the development of a pioneering gene therapy for the treatment of heart failure with a worldwide patent. He is a member of the German Society of Cardiology and the European Society of Cardiology. As a board member of the German Society of Traditional Chinese Medicine (DGTCM), he contributes to the integration of traditional Chinese medicine into Western medicine and serves as the responsible scientific coordinator and spokesperson. His impressive career and multifaceted commitment have had a lasting impact on cardiovascular medicine and traditional Chinese medicine.